JANA FISCHER: Open Payments
NPI 1851356430 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 61 payments from 24 companies in 2025. Trend: 2023 $327 · 2024 $471 · 2025 $1,425
Food & beverage: $1,425
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $513 |
| ABBVIE INC. | 13 | $179 |
| Neurocrine BioSciences, Inc. | 5 | $118 |
| UCB, Inc. | 3 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| PFIZER INC. | 2 | $37 |
| SK Life Science, Inc. | 2 | $35 |
| Tandem Diabetes Care, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Dexcom, Inc. | 1 | $31 |
Products named: PONVORY, INGREZZA, UBRELVY, QULIPTA, KESIMPTA, Briviact, NURTEC ODT, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across IN — which companies pay providers there.
